Brigitte Roos
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Pharmacogenetics and Drug Metabolism 7
- Antibiotics Pharmacokinetics and Efficacy 2
-
- Pharmaceutical studies and practices 2
- Co-authors
- Erhard Weidekamm (11 shared papers)Jim Cassidy (5 shared papers)Ludger Banken (5 shared papers)Bruno G. Reigner (5 shared papers)Masahiro Utoh (4 shared papers)Anne H. Schmitt‐Hoffmann (6 shared papers)Kazushige Mori (1 shared paper)Markus Heep (3 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (5 papers)Clinical and Experimental Dermatology (5 papers)Cancer Chemotherapy and Pharmacology (3 papers)Expert Review of Clinical Pharmacology (1 paper)PubMed (2 papers)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Brigitte Roos
16 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 74
- Oncology 576
- Infectious Diseases 373
- Pharmacology 188
- Geriatrics and Gerontology 31
- Pharmacology 98
Countries citing papers authored by Brigitte Roos
This map shows the geographic impact of Brigitte Roos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Roos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Roos more than expected).
Fields of papers citing papers by Brigitte Roos
This network shows the impact of papers produced by Brigitte Roos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Roos. The network helps show where Brigitte Roos may publish in the future.
Co-authors
The 25 scholars most cited alongside Brigitte Roos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 562 | |
| 2 | 2005 | 152 | |
| 3 | Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients. | 1998 | 140 |
| 4 | Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolites. | 1999 | 132 |
| 5 | 2005 | 124 | |
| 6 | 2004 | 92 | |
| 7 | 1999 | 81 | |
| 8 | 2004 | 74 | |
| 9 | 1999 | 64 | |
| 10 | 2009 | 63 | |
| 11 | 2011 | 17 | |
| 12 | 2011 | 14 | |
| 13 | 2011 | 12 | |
| 14 | 2011 | 12 | |
| 15 | 2012 | 10 | |
| 16 | 2011 | 9 |
About Brigitte Roos
Brigitte Roos is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health, Dermatology, Infectious Diseases and Oncology, having authored 16 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Antifungal resistance and susceptibility (3 papers), Retinoids in leukemia and cellular processes (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Dermatology and Skin Diseases (2 papers), Pregnancy and Medication Impact (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Oncology (576 citations), Infectious Diseases (373 citations), Pharmacology (188 citations), Geriatrics and Gerontology (31 citations) and Pharmacology (98 citations). Brigitte Roos has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Erhard Weidekamm, Jim Cassidy, Ludger Banken, Bruno G. Reigner, Masahiro Utoh, Anne H. Schmitt‐Hoffmann, Kazushige Mori, Markus Heep, Michael Schleimer and Jochen Spickermann. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Clinical and Experimental Dermatology, Cancer Chemotherapy and Pharmacology, Expert Review of Clinical Pharmacology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.